- Home
- ATAI vs OLMA Comparison
ATAI vs OLMA Comparison
Compare ATAI & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- OLMA
- Stock Information
- Founded
- ATAI 2018
- OLMA 2006
- Country
- ATAI Germany
- OLMA United States
- Employees
- ATAI N/A
- OLMA N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- ATAI Health Care
- OLMA Health Care
- Exchange
- ATAI Nasdaq
- OLMA Nasdaq
- Market Cap
- ATAI 291.5M
- OLMA 289.0M
- IPO Year
- ATAI 2021
- OLMA 2020
- Fundamental
- Price
- ATAI $1.24
- OLMA $3.34
- Analyst Decision
- ATAI Strong Buy
- OLMA Strong Buy
- Analyst Count
- ATAI 4
- OLMA 4
- Target Price
- ATAI $9.00
- OLMA $26.75
- AVG Volume (30 Days)
- ATAI 1.7M
- OLMA 906.8K
- Earning Date
- ATAI 03-17-2025
- OLMA 03-18-2025
- Dividend Yield
- ATAI N/A
- OLMA N/A
- EPS Growth
- ATAI N/A
- OLMA N/A
- EPS
- ATAI N/A
- OLMA N/A
- Revenue
- ATAI $308,000.00
- OLMA N/A
- Revenue This Year
- ATAI N/A
- OLMA N/A
- Revenue Next Year
- ATAI $20.00
- OLMA N/A
- P/E Ratio
- ATAI N/A
- OLMA N/A
- Revenue Growth
- ATAI N/A
- OLMA N/A
- 52 Week Low
- ATAI $1.03
- OLMA $3.29
- 52 Week High
- ATAI $2.85
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- ATAI 36.74
- OLMA 24.94
- Support Level
- ATAI $1.42
- OLMA $3.93
- Resistance Level
- ATAI $1.58
- OLMA $4.26
- Average True Range (ATR)
- ATAI 0.12
- OLMA 0.32
- MACD
- ATAI -0.00
- OLMA -0.03
- Stochastic Oscillator
- ATAI 4.55
- OLMA 4.08
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.